E-LIB Suche - Ergebnisse für: Öjlert, Åsa Kristina

1

Outcome prediction based on [18F]FDG PET/CT in patients wit..:

Thunold, Solfrid ; Hernes, Eivor ; Farooqi, Saima...
European Journal of Nuclear Medicine and Molecular Imaging. , 2024

2

UV1 telomerase vaccine with ipilimumab and nivolumab as sec..:

Haakensen, Vilde Drageset ; Öjlert, Åsa Kristina ; Thunold, Solfrid...
European Journal of Cancer. 202 (2024) - p. 113973 , 2024

Link: https://doi.org/10.1016/..

3

Atezolizumab and stereotactic body radiotherapy in patients..:

Horndalsveen, Henrik ; Alver, Tine Norman ; Dalsgaard, Astrid Marie...
Molecular Oncology. 17 (2022) 3 - p. 487-498 , 2022

Link: https://doi.org/10.1002/..

4

Dynamic changes in the T cell receptor repertoire during tr..:

Öjlert, Åsa Kristina ; Nebdal, Daniel ; Snapkov, Igor...
Molecular Oncology. 15 (2021) 11 - p. 2958-2968 , 2021

Link: https://doi.org/10.1002/..

5

Protein Kinase C Isozymes Associated With Relapse Free Surv..:

Halvorsen, Ann Rita ; Haugen, Mads Haugland ; Öjlert, Åsa Kristina...
Frontiers in Oncology. 10 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

6

Immune checkpoint blockade in the treatment of advanced non..:

Öjlert, Åsa Kristina ; Nebdal, Daniel ; Lund-Iversen, Marius...
Acta Oncologica. 60 (2020) 2 - p. 149-156 , 2020

Link: https://doi.org/10.1080/..

7

Identification of microRNAs involved in pathways which char..:

Halvorsen, Ann Rita ; Ragle Aure, Miriam ; Õjlert, Åsa Kristina...
Molecular Oncology. 13 (2019) 12 - p. 2604-2615 , 2019

Link: https://doi.org/10.1002/..

8

The immune microenvironment in non‐small cell lung cancer i..:

Öjlert, Åsa Kristina ; Halvorsen, Ann Rita ; Nebdal, Daniel...
Molecular Oncology. 13 (2019) 5 - p. 1166-1179 , 2019

Link: https://doi.org/10.1002/..

9

UV1 telomerase vaccine with ipilimumab and nivolumab as sec..:

Haakensen, Vilde Drageset ; Öjlert, Åsa Kristina ; Thunold, Solfrid...
European Journal of Cancer;202. , 2024

Link: https://hdl.handle.net/1..

10

UV1 telomerase vaccine with ipilimumab and nivolumab as sec..:

Haakensen, Vilde Drageset ; Öjlert, Åsa Kristina ; Thunold, Solfrid...
https://vbn.aau.dk/da/publications/67968dc0-90e5-4bd9-87c8-fb8f7c298508. , 2024

Link: https://vbn.aau.dk/da/pu..

11

Atezolizumab and stereotactic body radiotherapy in patients..:

Horndalsveen, Henrik ; Alver, Tine Norman ; Dalsgaard, Astrid Marie...
Horndalsveen, Henrik Alver, Tine Norman Dalsgaard, Astrid Marie ROGG, LOTTE VICTORIA Helbekkmo, Nina Grønberg, Bjørn Henning Halvorsen, Tarje Onsøien Ramberg, Christina Haakensen, Vilde Drageset Øjlert, Åsa Kristina Bjaanæs, Maria Moksnes Helland, Åslaug . Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial. Molecular Oncology. 2022. , 2022

Link: http://hdl.handle.net/10..

12

Atezolizumab and stereotactic body radiotherapy in patients..:

Horndalsveen, Henrik ; Alver, Tine Norman ; Dalsgaard, Astrid Marie...
urn:issn:1574-7891. , 2022

Link: https://hdl.handle.net/1..

13

Atezolizumab and stereotactic body radiotherapy in patients..:

Horndalsveen, Henrik ; Alver, Tine Norman ; Dalsgaard, Astrid Marie...
Molecular Oncology. , 2022

Link: https://hdl.handle.net/1..

14

Protein kinase C isozymes associated with relapse free surv..:

Halvorsen, Ann Rita ; Haugen, Mads Haugland ; Øjlert, Åsa Kristina...
http://urn.nb.no/URN:NBN:no-87083. , 2021

Link: http://hdl.handle.net/10..

15

Immune checkpoint blockade in the treatment of advanced non..:

Øjlert, Åsa Kristina ; Nebdal, Daniel J.H ; Lund-Iversen, Marius...
http://urn.nb.no/URN:NBN:no-85994. , 2021

Link: http://hdl.handle.net/10..